| Sandoz Pharmaceuticals AG - Pemetrexed Sandoz conc. 500 mg/20 ml, Konzentrat zur Herstellung einer Infusionslösung |
| 66501 | | 02 | | Pemetrexed Sandoz conc. 500 mg/20 ml | | Konzentrat zur Herstellung einer Infusionslösung | | L01BA04 | | Pemetrexed | | 17.07.2018 | | |
|
| Composition |
| pemetrexedum 500.0 mg ut pemetrexedum dinatricum hemipentahydricum 604.2 mg, natrii thiosulfas, propylenglycolum 1000.0 mg, acidum hydrochloridum, natrii hydroxidum, nitrogenium, aqua ad iniectabile q.s. ad solutionem pro 20 ml corresp. natrium 56.7 mg. |
| Packungsbestandteile |
| Concentré pour perfusion | | | | | | | | Principe actif | Concentr. |
|---|
| Pemetrexed | 500mg / 20ml |
| | BAG: Principe actif | Concentr. |
|---|
| Pemetrexed | 500 mg |
| | | | Agents auxilliaires | Concentr. |
|---|
| Acidum Hydrochloridum | | | Sodium Hydroxide | | | Sodium Thiosulfate | | | Nitrogenium | | | Propylenglycol | 1000mg / 20ml |
| |
|
|
